Prusky Lab
News & Impact

You are here

Reduction of Visual Impairment with Elamipretide in Rodent Models of Diabetes, Aging, and Retinitis Pigmentosa

PRESENTATION: 
Invited Talk
May 2019
Venue: 
Stealth Biotherapeutics, Inc, Boston, MA

We have had success in reducing visual impairment in rodent models of aging and retinal disease, by targeting and improving mitochondrial function with a drug called Elamipretide. The results have already stimulated successful human clinical trials for visual indications, and the approach holds promise to extend the visual healthspan as we age. 

Associated

Conditions & Recovery

Retinal Degenerative Diseases icon
Will double by 2050.
Vision Recovery icon
See better.

Research Methods